Estimated Increase in Mean Lifetime Survival for Glioblastoma Patients Age 65 Years and Older Treated with Tumor Treating Fields and Temozolomide Compared to Patients Treated with Temozolomide Alone Guzauskas, G. F., Pollom, E., Wang, B. M. ELSEVIER SCIENCE INC. 2018: E244–E245

View details for DOI 10.1016/j.ijrobp.2018.07.815

View details for Web of Science ID 000447811600561